1. United States of America Stocks

  2. •

    Industrials

  3. •

    Specialty Business Services
ADARx Pharmaceuticals, Inc.

ADARx Pharmaceuticals, Inc.

ADRX
ADARx Pharmaceuticals, Inc.US flagNASDAQ
18.25
USD
-1.29
- -
1.87BMarket Cap
ADARx Pharmaceuticals, Inc.
ADRX
(NASDAQ)

Recent

price

18.25

P/E

ratio

- -

div

yld

- -

ROIC.AI

2024
2025
FRC
- -
0.05
Revenue per Share
-0.62
-0.97
Basic EPS, GAAP
-0.65
3.44
Free Cash Flow per Basic Share
- -
- -
Dividend per Share
-1.34
-1.98
Book Value per Share
-1.34
-1.98
Tangible Book Value per Share
75
75
Basic Weighted Avg Shares
- -
3
Sales/Revenue/Turnover
- -
-2,562.05
Operating Margin (%)
2
2
Depreciation Expense
-46
-73
Net Income, GAAP
- -
- -
Effective Tax Rate (%)
- -
-2,119.11
Profit Margin (%)
217
463
Working Capital
4
6
LT Debt
-137
-202
Total Equity
- -
- -
Return on Invested Capital (%)
- -
- -
Return on Capital (%)
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
47.48%
Free Cash Flow
- -
- -
-629.1%
Net Income, GAAP
- -
- -
57.65%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
3
2026
2
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.62
2025
-0.21
- -
- -
- -
-0.97
2026
-0.22
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Choksi Laboratories Limited (CHOKSILA.BO)
Metrofile Holdings Limited (MFL.JO)
Neway Group Holdings Limited (0055.HK)
CMS Info Systems Limited (CMSINFO.NS)
Mobilized Entertainment, Inc (MENI)
Hongbo Co., Ltd. (002229.SZ)
Business
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.

Company News

Company News APIChatGPT

  • globenewswire.com

    ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares Granted in Its Initial Public Offering

  • gurufocus.com

    First Look: Disney Layoffs, Apple Smart Home Launch, Goldman CEO Talks

  • reuters.com

    ADARx Pharmaceuticals raises $446.3 million in upsized US IPO

  • globenewswire.com

    ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering